Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
R&D to Revenue
9.40%
Quarterly · Period ending:
BIO R&D to Revenue
Latest reported9.40%period ending
Latest reported9.40%period ending
BIO Quarterly R&D/Revenue (0.00% → 9.40%)
Latest values, visible window
High-resolution chart · PNG
BIO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 9.4009% | |
| 10.6232% | |
| 9.4778% | |
| 10.9188% | |
| 9.2848% | |
| 12.5555% | |
| 11.9291% | |
| 14.0054% | |
| 9.2884% | |
| 10.4736% | |
| 9.1331% | |
| 6.8871% | |
| 9.5494% | |
| 11.0736% | |
| 9.0649% | |
| 10.2745% | |
| 9.6996% | |
| 8.5042% | |
| 9.5355% | |
| 8.6314% | |
| 8.8543% | |
| 10.1696% | |
| 8.3264% | |
| 9.1997% | |
| 9.6826% | |
| 8.6248% | |
| 9.1394% | |
| 8.5518% | |
| 8.7531% | |
| 8.5879% | |
| 8.5944% | |
| 9.0335% | |
| 8.2391% | |
| 8.962% | |
| 12.3814% | |
| 11.4713% | |
| 12.4088% | |
| 9.8966% | |
| 10.0696% | |
| 9.8132% | |
| 10.0955% | |
| 10.3112% | |
| 9.7952% | |
| 9.2212% | |
| 9.1972% | |
| 9.9831% | |
| 9.9105% | |
| 9.9475% | |
| 10.3789% | |
| 10.3158% | |
| 9.2673% | |
| 10.4778% | |
| 10.1317% | |
| 10.395% | |
| 10.417% | |
| 9.8264% | |
| 10.2535% | |
| 10.8833% | |
| 9.1073% | |
| 8.7872% | |
| 9.2417% | |
| 8.8081% | |
| 8.4814% | |
| 9.0931% | |
| 9.379% | |
| 8.8639% | |
| 8.9906% | |
| 8.5708% | |
| 9.9271% | |
| 9.2664% | |
| 9.1793% | |
| 8.7882% | |
| 9.3021% | |
| 8.8795% | |
| 8.67% | |
| 9.7559% | |
| 10.2485% | |
| 10.1644% | |
| 9.7137% | |
| 10.1679% | |
| 9.7471% | |
| 9.1105% | |
| 10.1238% | |
| 10.1238% | |
| 9.7833% | |
| 8.9658% | |
| 10.3567% | |
| 10.2689% | |
| 9.8044% | |
| 9.7973% | |
| 9.9086% | |
| 9.5977% | |
| 9.3348% | |
| 8.6954% | |
| 9.4239% | |
| 8.8884% | |
| 9.2267% | |
| 9.6302% | |
| 9.4219% | |
| 9.9004% |